Carol A. Nacy
Carol A. Nacy (born 1948) is a microbiologist and immunologist focused on the immune response of bacterial and parasitic disease.[1][2]
Education and academic career
[edit]Nacy did her undergraduate and PhD studies at Catholic University in Washington, DC receiving her degree in 1976.[3][4] She did her postdoc work at the Walter Reed Army Institute of Research in the Department of Rickettsial Diseases and then became a staff scientist at the same institute for 17 years.[5] Her research concerned the understanding and treatment of a number of infections including those caused by Francisella tularensis and Leishmania major.[2]
Industrial career
[edit]Nacy founded Sequella in 1997 and continues as CEO.[5] Sequella focuses on clinical stage antibiotic development, in particular against Mycobacterium tuberculosis (TB).[6]
Awards and honors
[edit]Nacy was the president of the American Society of Microbiology (1996-1997)[1] and the Society for Leukocyte Biology (1992).[7] She was awarded the Lifetime Achievement Award in Science at Catholic University in 2002. Women in BIO[8] named her Entrepreneur of the Year (2004) and honored her with a Special Outstanding Achievement Award for Clinical Trials (2007). In December 2009 she was awarded the Humanitarian Award, Hope is a Vaccine, by the Global Alliance for Immunization against Aids (GAIA) for her work to create new drugs for TB.[4][9]
Personal life
[edit]Nacy is married to Monte S. Meltzer, M.D., has 5 children and 3 grandchildren.[4]
References
[edit]- ^ a b Yee, Karen. "LibGuides: Center for the History of Microbiology/ASM Archives (CHOMA): Reference Documents". lib.guides.umbc.edu. Retrieved 2020-07-16.
- ^ a b Many faces, many microbes : personal reflections in microbiology. Atlas, Ronald M., 1946-. Washington, D.C.: ASM Press. 2000. ISBN 1-55581-190-6. OCLC 43287411.
{{cite book}}: CS1 maint: others (link) - ^ "Carol Nacy". Retrieved July 16, 2020.
- ^ a b c Immunology 2010. "Nacy biography" (PDF). Archived (PDF) from the original on 2020-07-16. Retrieved July 16, 2020.
{{cite web}}: CS1 maint: numeric names: authors list (link) - ^ a b "Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance BioBuzz". BioBuzz. 2018-08-27. Retrieved 2020-07-16.
- ^ "Sequella Overview". www.sequella.com. Retrieved 2020-07-16.
- ^ "Society of Leukocyte Biology newsletter" (PDF). Archived (PDF) from the original on 2020-07-17. Retrieved July 16, 2020.
- ^ "Women In Bio". Women In Bio. Retrieved 2020-07-16.
- ^ "2009 Hope is a Vaccine Award Ceremony". Gaia Vaccine Foundation. Retrieved 2020-07-16.